Ohio SB170 allows eligible patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments.
Ohio SB170 revises state law to allow eligible patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. An eligible patient must have a condition that is fatal without intervention, severely debilitating, or causes major irreversible morbidity. The bill defines "individualized investigational treatment" as a drug, biological product, or device tailored to a patient's genetic profile.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.